P. Whiteman
Impact in
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
Papers in
-
- Herpesvirus Infections and Treatments 6
- Cytomegalovirus and herpesvirus research 5
-
- Metabolism and Genetic Disorders 4
- Co-authors
- D. Brigden (2 shared papers)P de Miranda (1 shared paper)Lilia M. Beauchamp (1 shared paper)H. J. Schaeffer (1 shared paper)Thomas A. Krenitsky (1 shared paper)Willard W. Hall (1 shared paper)John Posner (4 shared papers)J. E. Scott (1 shared paper)
- Journals
- European Journal of Clinical Pharmacology (4 papers)Archives of Disease in Childhood (2 papers)Biochemical Journal (2 papers)British Journal of Clinical Pharmacology (1 paper)Journal of Infection (1 paper)
- Partner nations
- United KingdomGreeceCanada
In The Last Decade
P. Whiteman
19 papers receiving 908 citations
Peers
Comparison fields: 5 of 101
- Cell Biology 224
- Rheumatology 128
- Pharmacology 78
- Immunology and Allergy 49
- Clinical Biochemistry 53
Countries citing papers authored by P. Whiteman
This map shows the geographic impact of P. Whiteman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Whiteman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Whiteman more than expected).
Fields of papers citing papers by P. Whiteman
This network shows the impact of papers produced by P. Whiteman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Whiteman. The network helps show where P. Whiteman may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Whiteman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1973 | 287 | |
| 2 | 1984 | 146 | |
| 3 | 1973 | 144 | |
| 4 | 1974 | 68 | |
| 5 | 1985 | 48 | |
| 6 | 1983 | 43 | |
| 7 | 1987 | 38 | |
| 8 | 1984 | 37 | |
| 9 | 1985 | 36 | |
| 10 | 1974 | 30 | |
| 11 | The clinical pharmacology of acyclovir and its prodrugs. | 1985 | 23 |
| 12 | 1984 | 22 | |
| 13 | 1984 | 16 | |
| 14 | 1986 | 14 | |
| 15 | 1979 | 13 | |
| 16 | 1981 | 12 | |
| 17 | 1986 | 8 | |
| 18 | 1972 | 6 | |
| 19 | 1983 | 2 |
About P. Whiteman
P. Whiteman is a scholar working on Epidemiology, Clinical Biochemistry, Pediatrics, Perinatology and Child Health, Cell Biology and Molecular Biology, having authored 19 papers that have together received 993 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (5 papers), Metabolism and Genetic Disorders (4 papers), Glycosylation and Glycoproteins Research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Polysaccharides and Plant Cell Walls (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Cell Biology (224 citations), Rheumatology (128 citations), Pharmacology (78 citations), Immunology and Allergy (49 citations) and Clinical Biochemistry (53 citations). P. Whiteman has collaborated with scholars based in United Kingdom, Greece and Canada. Frequent co-authors include D. Brigden, P de Miranda, Lilia M. Beauchamp, H. J. Schaeffer, Thomas A. Krenitsky, Willard W. Hall, John Posner, J. E. Scott, Alan Bye and A. W. Peck. Their work appears in journals such as European Journal of Clinical Pharmacology, Archives of Disease in Childhood, Biochemical Journal, British Journal of Clinical Pharmacology and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.